Diabetes drug points the way to overcoming drug resistance in melanoma (EurekAlert, 11 June 2013)

12 Jun 2013


A US-Germany collaboration, published in Cancer Cell, investigates the use of the diabetes drug phenformin in vitro and in mice to improve the efficacy of anti-melanoma drugs against a subpopulation of melanoma cells that exhibit resistance to chemotherapy and a very high metabolic rate.

Full article


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story